Recurrent Breast Cancer Withdrawn Phase 3 Trials for Tamoxifen (DB00675)

Also known as: Breast Cancer Recurrent / Breast cancer NOS recurrent / Carcinoma breast recurrent / Breast carcinoma recurrent / Breast carcinoma NOS recurrent

IndicationStatusPhase
DBCOND0028640 (Recurrent Breast Cancer)Withdrawn3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00053339Trastuzumab With or Without Tamoxifen in Treating Women With Progressive Stage IV Breast CancerTreatment